Trulieve Hosts Framingham, Massachusetts Grand Opening Celebration

Third dispensary in Massachusetts to open offers an elevated in-store experience;   Celebration on April 9 includes celebrity appearances, giveaways and deals

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States is pleased to announce the opening of a dispensary in Framingham, Massachusetts on Sunday, April 3 . Located in New England's Golden Triangle retail district at 85 Worcester Rd., the new dispensary provides an elevated in-store experience. This is Trulieve's third and largest retail location in Massachusetts .

At more than 5,000 square feet, the Trulieve Framingham showroom will offer a fresh, spacious, contemporary look with elegant finishes. The updated configuration allows customers to browse and explore in an interactive space. The dispensary will open as an adult-use dispensary and expand to include medical cannabis later this Spring.

The grand opening celebration on Saturday, April 9 will include several dignitary and celebrity appearances, executive meet & greets, live brand activations, giveaways, food trucks, all day in-store promotional offers, and more. Register for exclusive Framingham updates and events at enrollnow.vip/join/3542 .

"We are thrilled to offer a more elevated experience for Trulieve customers and patients," said Kim Rivers , Chief Executive Officer of Trulieve. "This is a tremendous milestone in Trulieve's Northeast growth, and we look forward to providing exceptional customer service to a variety of patients and customers with our high-quality products."

Trulieve focuses on growing safe, quality cannabis and continually works to provide a wide variety of innovative products for adult use customers and medical patients in Massachusetts. Trulieve will offer a wide selection of cannabis products and in-house brands such as:

  • Momenta – Trulieve's staple cannabis line for everyday wellness and overall well-being. The product lineup includes tinctures, nano tinctures, capsules, RSO and a topical muscle gel.
  • Sweet Talk – Trulieve's line of tasty edibles, including craveable chocolates and gummies infused with premium quality cannabis.
  • Muse – Trulieve's line of premium, cannabis concentrates and cartridges.
  • Cultivar Collection – Premium group of small-batch, top-shelf cannabis. Each unique strain is carefully bred to deliver undeniably rich flavor and potent terpenes.

In addition to Trulieve's proprietary brands, customers and patients will have access to beloved partner brands such as Bhang, Binske, Blue River, O.pen, Puffco, and Slang. Trulieve is also the exclusive provider of clones in the Massachusetts market.

Trulieve is partnering with Dr. Marion McNabb's team at the Cannabis Center of Excellence (CCOE) to support the non-profit's ongoing medical cannabis research. The CCOE's study was first approved in March 2021 by the University of Massachusetts Dartmouth to collect information from healthcare providers in both the U.S. and Canada about their knowledge, attitude, and practices related to medical cannabis.

Additional Trulieve dispensaries in Massachusetts are located in Northampton and Worcester . For more information on store activations, promotions and locations, please visit trulieve.com/dispensaries/massachusetts .

About Trulieve

Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .

Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve

Investor Contact

Christine Hersey , Executive Director of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

Media Contact

Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
Robert.Kremer@Trulieve.com

MATTIO Communications
Trulieve@Mattio.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-hosts-framingham-massachusetts-grand-opening-celebration-301518583.html

SOURCE Trulieve Cannabis Corp.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/April2022/06/c7777.html

News Provided by Canada Newswire via QuoteMedia

TCNNF,TRUL:CNX
The Conversation (0)

Trulieve to Open Medical Cannabis Dispensary in Columbus, Georgia

New Muscogee County location will host grand opening celebration Friday, December 20 th

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF )  ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical cannabis dispensary in Columbus, Georgia .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve to Open Medical Cannabis Dispensary in Tampa, Florida

New Hillsborough County location will host grand opening celebration Friday December 13

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Tampa, Florida .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Cannabis leaves, US flag.

Cannabis Round-Up: DEA Postpones Rescheduling Hearing, Key Players Share Quarterly Results

November was a busy month for the cannabis industry, with a slew of US-centric developments.

A hearing on cannabis rescheduling was postponed until 2025, although the incoming Trump administration has signaled its intent to follow through on the change despite opposition from some Republican lawmakers.

Meanwhile, several states voted on cannabis measures, and companies reported their latest quarterly results.

Keep reading...Show less
Cannabis plants and a stock chart.

US Cannabis Sales Hit Record in October, Market Set to Reach US$55 Billion by 2030

Cannabis sales in the US reached a record high in October, with retail transactions totaling approximately US$2.8 billion, according to data from LeafLink, a wholesale cannabis platform.

While sales saw a slight 2.1 percent dip compared to September, they were up 6.2 percent year-on-year. Total retail cannabis sales in 2024 are expected to hit US$32.6 billion, representing a 10.8 percent increase over the previous year.

LeafLink attributes much of this growth to new licenses in states such as New York, New Jersey and Ohio.

Keep reading...Show less
Australia flag and cannabis.

Australian Senate Rejects Greens' Bill to Legalise Cannabis

The Australian Greens announced on Wednesday, November 27, that the Legalising Cannabis Bill 2023 was defeated in a 13 to 24 vote, preventing the federal legalisation of cannabis.

“The Labor and Coalition parties joined together to try and hold Australia back in the 1950s by blocking this desperately needed reform,” said Greens Senator for New South Wales David Shoebridge.

Shoebridge said on X that the parties “teamed up” to vote against legalizing cannabis in the Senate, “yet another example of the major parties working together to refuse any sort of progress.”

All 11 Greens Senators voted in favour of the Bill, as did Independent Senators Lidia Thorpe and Tammy Tyrrell.

Keep reading...Show less
Cannabis and Australian money.

Victoria Amends Driving Rules for Medicinal Cannabis Users, Changes Effective in Mid-2025

Both houses of parliament in Victoria, Australia, have successfully passed the Roads and Road Safety Legislation Amendment Bill 2024, Cannabis Council Australia said in a recent newsletter.

The organisation sees this as a “promising development” in the area, calling it a “critical legislative milestone." The bill's passing will allow for judicial discretion when decisions about medicinal cannabis are made.

Magistrates will now have the ability to evaluate individual cases where drivers who hold valid medicinal cannabis prescriptions test positive for THC, but show no signs of impairment.

Keep reading...Show less

Latest Press Releases

Related News

×